Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. Use of Antiemetic Agents in Acute Gastroenteritis 3. 2008 Exclusive Survey—Earnings: Good news for primary care income 4. A randomised phase III study on capecitabine, oxaliplatin and bevacizumab with or without cetuximab in first-line advanced colorectal cancer, the CAIRO2 study of the Dutch Colorectal Cancer Group (DCCG). An interim analysis of toxicity 5. Medicare pay-for-reporting effort draws fire from frustrated doctors
Your Article Summary
See Latest ArticlesAnnual Change of Primary Resistance to Clarithromycin among Helicobacter pylori Isolates from 1996 through 2008 in Japan
Helicobacter, 09/14/09
Horiki N et al. – The resistance rate of H. pylori infection to clarithromycin in Japan has increased gradually to approximately 30% from 1996 through 2004, and remained unchanged since 2004. Elderly and females were at high risk of having resistance to clarithromycin. The authors' results suggested that the level of clarithromycin resistance in Japan has now risen to the point where it should no longer be used as empiric therapy.
Related Articles
Peptic ulcer disease and helicobacter pylori infection at kano, nigeria
The Internet Journal of Gastroenterology, 11/11/09
Relevance Score: 69%
Reactive Nitrogen Species Mediate DNA Damage in Helicobacter pylori-Infected Gastric Mucosa
Helicobacter, 11/09/09
Relevance Score: 68%
Helicobacter pylori infection in children: population-based age-specific prevalence and risk factors in a developing country
Acta Pediatrica, 10/28/09
Relevance Score: 68%
In-vitro interaction of l-dopa with bacterial adhesins of Helicobacter pylori: an explanation for clinicial differences in bioavailability
Journal of Pharmacy and Pharmacology, 10/14/09
Relevance Score: 68%
Analysis of Clarithromycin Resistance and CagA Status in Helicobacter pylori Using Feces from Children in Thailand
Journal of Clinical Microbiology, 10/08/09
Relevance Score: 68%
Today in GI Infectious Disease...keeping you current
Receive free subspecialty "5-minute updates" via email
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/17/09
The effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study
Alimentary Pharmacology and Therapeutics, 12/17/09
Geographic map and evolution of primary Helicobacter pylori resistance to antibacterial agents
Expert Review of Anti-infective Therapy, 12/17/09
Today in Pharmacology/kinetics...keeping you current
Receive free subspecialty "5-minute updates" via email
A prospective phase II study of cetuximab in combination with XELOX (capecitabine and oxaliplatin) in patients with metastatic and/or recurrent advanced gastric cancer
Investigational New Drugs, 12/17/09
Pilot study: the use of sulfasalazine for the treatment of acute pouchitis
Alimentary Pharmacology and Therapeutics, 12/17/09
Clinical outcome of newly diagnosed Crohns disease: a comparative, retrospective study before and after infliximab availability
Alimentary Pharmacology and Therapeutics, 12/17/09
Sponsor
Article Search
Sponsor
Sponsor